advanced search

Ophthalmic Drug Delivery94

Issue No #94  January 14th, 2019


Download PDF


Issue 94 - Jan 2019

Inside the magazine

USING MARKET RESEARCH TO CREATE A PRESERVATIVE-FREE MULTIDOSE EYEDROPPER
OCULAR
Thomas Grinnan
Silgan Dispensing
USING MARKET RESEARCH TO CREATE A PRESERVATIVE-FREE MULTIDOSE EYEDROPPER
Thomas Grinnan and Ralf Hergenröther explain how extensive market research and consumer testing led to the development of an eyedropper that meets patients’ and physicians’ needs for an easy-to-use device, which offers precise dosing and anti-microbial integrity.
USER TESTING: CRITICAL FOR TRULY UNDERSTANDING PATIENT NEEDS
OCULAR
Fanny Sellier
Nemera
USER TESTING: CRITICAL FOR TRULY UNDERSTANDING PATIENT NEEDS
Fanny Sellier presents a trio of comparative user studies between Nemera’s Novelia® preservative-free, multidose eyedropper and similar products from competitors
ACCURATE, PRECISE MICROLITRE DOSING WITH PREFILLABLE SYRINGES FOR OPHTHALMIC INJECTIONS
OCULAR
Dr Gautam Shetty
Congruence Medical Solutions
ACCURATE, PRECISE MICROLITRE DOSING WITH PREFILLABLE SYRINGES FOR OPHTHALMIC INJECTIONS
Gautam Shetty discusses the challenges inherent to delivering microlitre dosage volumes accurately from a standard prefilled syringe, and introduces Congruence’s Microlitre Dosing Syringe (MDS) platform as a solution.
BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE
OCULAR
Dr Christian Roesky
BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE
Christian Roesky discusses the underserved condition of dry eye disease, and presents two products in Novaliq’s pipelinefor the treatment of different types of DED.
KEEPING PRESERVATIVE-FREE EYEDROPS STERILE WITH THE STERIDROP™ TUBE
OCULAR
Ralf Künzi
KEEPING PRESERVATIVE-FREE EYEDROPS STERILE WITH THE STERIDROP™ TUBE
Ralf Künzi introduces the SteriDrop™ tube – a new multidose eyedrop delivery solution made in collaboration with Aptar Pharma.
THE CHALLENGES AND OPPORTUNITIES OF DRUG DELIVERY THROUGH A COMPLEX BARRIER
OCULAR
Dr Jon Volmer
MedPharm
THE CHALLENGES AND OPPORTUNITIES OF DRUG DELIVERY THROUGH A COMPLEX BARRIER
Jon Volmer, Marc Brown and Jeremy Drummond discuss the development and use of advanced ex vivo and in vitro models for testing new ocular medicines to meet a growing unmet need.
TARGETING DRUGS TO DISEASED OCULAR CELLS
EARLY INSIGHT
Frazer P Coutinho
TARGETING DRUGS TO DISEASED OCULAR CELLS
Frazer Coutinho, Colin Green and Ilva Rupenthal discuss the targeted delivery of ocular therapeutics to diseased cells, using the cell-penetrating peptide, Xentry.
INTRAVITREAL INJECTION OF VEGF INHIBITORS – IMPACT OF DRUG CONTAINERS
EXPERT VIEW
Douglas Cusato
INTRAVITREAL INJECTION OF VEGF INHIBITORS – IMPACT OF DRUG CONTAINERS
With the increasing use of intravitreal injections of vascular endothelial growth factor inhibitors in the treatment of numerous serious ocular diseases, Douglas Cusato provides a detailed comparative analysis of the issues at play.
ACUSTREAM™: BRINGING TOPICAL OPHTHALMIC DRUG DELIVERY INTO THE MODERN ERA
OCULAR
Dr Peter Noymer
ACUSTREAM™: BRINGING TOPICAL OPHTHALMIC DRUG DELIVERY INTO THE MODERN ERA
Peter Noymer, Ehud Ivri, Reynaldo Quintana and Mark Blumenkranz introduce AcuStream, a novel device for next-generation delivery of topical ophthalmic delivery via an aim-assisted stream.
TRENDS IN ANTI-GLAUCOMA TOPICAL TREATMENTS
OCULAR
Rouven Kraus
Aero Pump
TRENDS IN ANTI-GLAUCOMA TOPICAL TREATMENTS
Rouven Kraus presents the case for multidose delivery systems rather than single-use disposables, and introduces Aero Pump’s Ophthalmic Multidose System.
Top